Xiao Yu

8.0k citations

57 papers · 3.0k indexed · 1 hit paper · h-index 22

Impact in

Immunology top 5%
- interferon and immune responses
Molecular Biology top 5%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors

Papers in ⓘ

Immunology 27
- interferon and immune responses 15
- Immune Cell Function and Interaction 4
Molecular Biology 34
- Inflammasome and immune disorders 8
- Cell death mechanisms and regulation 5

Co-authors: Sha Jin (3 shared papers)Michael J. Mitten (4 shared papers)Steven W. Elmore (4 shared papers)Saul H. Rosenberg (4 shared papers)Stephen W. Fesik (4 shared papers)Christin Tse (4 shared papers)Stephen K. Tahir (4 shared papers)Alexander R. Shoemaker (3 shared papers)
Journals: Cancer Research (3 papers)mBio (3 papers)Blood (3 papers)Nature Communications (2 papers)Frontiers in Immunology (2 papers)
Partner nations: China United States Thailand

In The Last Decade

Xiao Yu

53 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor 2008 · 1.5k citations

Peers

Countries citing papers authored by Xiao Yu

Since Specialization

Citations

This map shows the geographic impact of Xiao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Yu more than expected).

Fields of papers citing papers by Xiao Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Yu. The network helps show where Xiao Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiao Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiao Yu Line = papers co-authored together Xiao Yu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor Cancer Research ·Christin Tse, Alexander R. Shoemaker, Jessica Adickes, Mark G. Anderson, Jun Chen, Sha Jin, Eric F. Johnson, Kennan C. Marsh, Michael J. Mitten, Paul Nimmer, Lisa Roberts, Stephen K. Tahir, Xiao Yu, Xiufen Yang, Haichao Zhang, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore Hit paper breakdown →	2008	1513
2	Antimicrobial and anti-biofilm activity of tannic acid against Staphylococcus aureus Natural Product Research ·Guofeng Dong, Haiyang Liu, Xiao Yu, Xiaoxiao Zhang, Hong Lu, Tieli Zhou, Jianming Cao	2017	165
3	5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis Clinical Cancer Research ·Sha Jin, Dan Cojocari, Julie J. Purkal, Relja Popovic, Nari Talaty, Xiao Yu, Larry R. Solomon, Erwin R. Boghaert, Joel Johansson, Darren C. Phillips	2020	126
4	Microbiota regulate innate immune signaling and protective immunity against cancer Cell Host & Microbe ·Changsheng Xing, Mingjun Wang, Adebusola Alagbala Ajibade, Peng Tan, Chuntang Fu, Lang Chen, Motao Zhu, Zhao-Zhe Hao, Junjun Chu, Xiao Yu, Bingnan Yin, Jiahui Zhu, Wan-Jou Shen, Tianhao Duan, Helen Y. Wang, Rong‐Fu Wang	2021	116
5	The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo Cancer Chemotherapy and Pharmacology ·Scott Ackler, Michael J. Mitten, Kelly Foster, Anatol Oleksijew, Marion Refici, Stephen K. Tahir, Xiao Yu, Christin Tse, David J. Frost, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore, Alexander R. Shoemaker	2010	100
6	Induction and application of ferroptosis in cancer therapy Cancer Cell International ·Qing Nie, Yue Hu, Xiao Yu, Xiao Li, Xuedong Fang	2022	98
7	Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality Immunity ·Xiao Yu, Baowei Cai, Mingjun Wang, Peng Tan, Xilai Ding, Jian Wu, Jian Li, Qingtian Li, Pinghua Liu, Changsheng Xing, Helen Y. Wang, Xin‐zhuan Su, Rong‐Fu Wang	2016	96
8	Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality Proceedings of the National Academy of Sciences ·Jian Wu, Linjie Tian, Xiao Yu, Sittiporn Pattaradilokrat, Jian Li, Mingjun Wang, Weishi Yu, Weiqi Yan, Amir E. Zeituni, Sethu C. Nair, Steve P. Crampton, Marlene S. Orandle, Silvia Bolland, Chen‐Feng Qi, Carole A. Long, Timothy G. Myers, John E. Coligan, Rong‐Fu Wang, Xin‐zhuan Su	2014	74
9	ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo Molecular Cancer Therapeutics ·Scott Ackler, Xiao Yu, Michael J. Mitten, Kelly Foster, Anatol Oleksijew, Marion Refici, Sally Schlessinger, Baole Wang, Sanjay R. Chemburkar, Joy Bauch, Christin Tse, David J. Frost, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore, Alex R. Shoemaker	2008	64
10	Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling Molecular Cell ·Peng Tan, Lian He, Jun Cui, Qian Chen, Xin Cao, Meng Lin, Qingyuan Zhu, Yinyin Li, Changsheng Xing, Xiao Yu, Helen Y. Wang, Rong‐Fu Wang	2017	61
11	Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity Nature Communications ·Xiao Yu, Yang Du, Chunmei Cai, Baowei Cai, Motao Zhu, Changsheng Xing, Peng Tan, Meng Lin, Jian Wu, Jian Li, Mingjun Wang, Helen Y. Wang, Xin‐zhuan Su, Rong‐Fu Wang	2018	53
12	FOSL1 Inhibits Type I Interferon Responses to Malaria and Viral Infections by Blocking TBK1 and TRAF3/TRIF Interactions mBio ·Baowei Cai, Jian Wu, Xiao Yu, Xin‐zhuan Su, Rong-Fu Wang	2017	38
13	Vancomycin and ceftriaxone can damage intestinal microbiota and affect the development of the intestinal tract and immune system to different degrees in neonatal mice Pathogens and Disease ·Ru Cheng, Ming Li, Shan Shan Li, Miao He, Xiao Yu, Lei Shi, Fang He	2017	34
14	The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation Proceedings of the National Academy of Sciences ·Jian Wu, Lu Xia, Xiangyu Yao, Xiao Yu, Keyla C. Tumas, Wenxiang Sun, Yang Cheng, Xiao He, Yu-chih Peng, Brajesh K. Singh, Cui Zhang, Chen‐Feng Qi, Silvia Bolland, Sonja M. Best, D. Channe Gowda, Ruili Huang, Timothy G. Myers, Carole A. Long, Rong‐Fu Wang, Xin‐zhuan Su	2020	33
15	Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors Cancer Research ·Darren C. Phillips, Fritz G. Buchanan, Dong Cheng, Larry R. Solomon, Xiao Yu, John Xue, Stephen K. Tahir, Morey L. Smith, Haichao Zhang, D. L. Widomski, Vivek C. Abraham, Nan Xu, Zhihong Liu, Li Zhou, Enrico L. DiGiammarino, Xin Lü, Nandini Rudra-Ganguly, Bruce A. Trela, Susan E. Morgan-Lappe	2021	32
16	The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis Frontiers in Immunology ·Yingyu Wang, Zhongzhou Huang, Xiao Yu, Weiguo Wan, Xue Yang	2022	29
17	miR-375 Affects the Proliferation, Invasion, and Apoptosis of HPV16-Positive Human Cervical Cancer Cells by Targeting IGF-1R International Journal of Gynecological Cancer ·Xiao Yu, Weihong Zhao, Xin Yang, Zhilian Wang, Min Hao	2016	27
18	Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy Autophagy ·Huaji Jiang, Yingchao Xie, Jiansen Lu, Hongyu Li, Ke Zeng, Z. Hu, Dan Wu, Jianwu Yang, Zhenxia Yao, Huadan Chen, Xiaoqian Gong, Xiao Yu	2023	26
19	Function and regulation of cGAS-STING signaling in infectious diseases Frontiers in Immunology ·Yang Du, Zhiqiang Hu, Yien Luo, Helen Y. Wang, Xiao Yu, Rong‐Fu Wang	2023	26
20	Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development Journal of Clinical Investigation ·Peng Tan, Lian He, Changsheng Xing, Mao Jingrong, Xiao Yu, Motao Zhu, Lixia Diao, Leng Han, Yubin Zhou, James M. You, Helen Y. Wang, Rong‐Fu Wang	2019	25

About Xiao Yu

Xiao Yu is a scholar working on Immunology, Molecular Biology, Parasitology, Hematology and Periodontics, having authored 57 papers that have together received 3.0k indexed citations. Recurring topics across this work include interferon and immune responses (15 papers), Inflammasome and immune disorders (8 papers), Autophagy in Disease and Therapy (7 papers), Cell death mechanisms and regulation (5 papers), Immune Cell Function and Interaction (4 papers), Viral Infections and Vectors (4 papers), Malaria Research and Control (4 papers) and Mosquito-borne diseases and control (4 papers). The work is most often cited by research in Immunology (665 citations), Molecular Biology (1.9k citations), Hematology (292 citations), Oncology (608 citations) and Genetics (236 citations). Xiao Yu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Sha Jin, Michael J. Mitten, Steven W. Elmore, Saul H. Rosenberg, Stephen W. Fesik, Christin Tse, Stephen K. Tahir, Alexander R. Shoemaker, Haichao Zhang and Eric F. Johnson. Their work appears in journals such as Cancer Research, mBio, Blood, Nature Communications and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact